Central Petroleum Ltd Stock
Price
Target price
€0.041
€0.041
1.250%
0.0005
1.250%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Central Petroleum Ltd Stock
Central Petroleum Ltd gained 1.250% today.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Central Petroleum Ltd stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Central Petroleum Ltd in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Central Petroleum Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Central Petroleum Ltd | 1.250% | -1.220% | -10.000% | 35.000% | 24.615% | 22.727% | -39.098% |
| Beach Energy Ltd. | 0.000% | -5.000% | -7.639% | -6.993% | 5.556% | -18.902% | -13.072% |
| Strike Energy Ltd. | -0.690% | -0.694% | 9.160% | -23.936% | 28.829% | -74.464% | -64.250% |
| 88 Energy Ltd. | 27.450% | -9.722% | -1.515% | -2.256% | 12.069% | 188.889% | -7.143% |
News
Could Investing $1,000 in CENTA Make You Richer?
Most investors chasing consumer goods stocks gravitate toward big dividend payers or big names like Procter & Gamble and Church & Dwight. Those are fine businesses. They're also some of the
IDEAYA Biosciences Eyes Busy 2026 as Darovasertib Advances Toward FDA Filing
Key Points
- Interested in IDEAYA Biosciences, Inc.? Here are five stocks we like better.
- Darovasertib, IDEAYA’s lead drug, posted strong Phase I/II results in first-line HLA-A2 negative
Gilead Sciences Highlights Trodelvy Lung Data, Long-Acting HIV Pipeline at RBC Conference
Key Points
- Interested in Gilead Sciences, Inc.? Here are five stocks we like better.
- Trodelvy is a key near-term catalyst for Gilead, with management highlighting upcoming data in first-line